Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006

Vaccine

Volumn 26, Issue 44, 2008, Pages 5612-5618

  Murris Espin, Marlène ^a   Aubert, Marie ^b   Bosdure, Emmanuelle ^c   Dubus, Jean Christophe ^c  

^a SERVICE DE PNEUMOLOGIE   (France)

^b SANOFI PASTEUR   (France)

^c Timone Teaching Hospital   (France)

Author keywords

Cystic fibrosis; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTICIPATORY ANXIETY; ARTICLE; CHILD; CYSTIC FIBROSIS; DRUG CONTRAINDICATION; DRUG EFFICACY; FEMALE; FRANCE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; SAFETY; TIME; TRANSPLANTATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FRANCE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; SEASONS; VACCINATION;

EID: 52949154339     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.095     Document Type: Article

References (31)

1. World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 80 (2005) 279-287
2. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. July 13, 2007/56(RR-6);1-31. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5606a1.htm. Accessed 31 March 2008.
3. Loi relative à la politique de santé publique. Loi n(2004-806 du 9 août 2004. Available at: http://www.legifrance.gouv.fr Accessed 31 March 2008.
4. Flume P.A., O'Sullivan B.P., Robinson K.A., Goss C.H., Mogayzel Jr. P.J., and Willey-Courand D.B. Cystic fibrosis pulmonary guidelines chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 176 (2007) 957-969
5. Davies J.C., Alton E., and Bush A. Cystic fibrosis. Br Med J. 335 (2007) 1255-1259
6. Conway S.P., Simmonds E.J., and Littlewood J.M. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 47 (1992) 112-114
7. Ferson M.J., Morton J.R., and Robertson P.W. Impact of influenza on morbidity in children with cystic fibrosis. J Paediatr. Child Health 27 (1991) 308-311
8. Pribble C.G., Black P.G., Bosso J.A., and Turner R.B. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr. 117 (1990) 200-204
9. Wat D., Gelder C., Hibbitts S., Bowler I., Pierrepoint M., and Evans R. Is there a role for influenza vaccination in cystic fibrosis?. J Cyst Fibros. 7 (2008) 85-88
10. Ong E.L., Bilton D., Abbott J., Webb A.K., McCartney R.A., and Caul E.O. Influenza vaccination in adults with cystic fibrosis. BMJ 303 (1991) 557
11. Gruber W.C., Campbell P.W., Thompson J.M., Reed G.W., Roberts B., and Wright P.F. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis. 169 (1994) 241-247
12. Dharmaraj P, Tan A, Smyth R. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Systematic Reviews 2007, Issue 4. doi:10.1002/14651858. CD001753 Available at: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001753/frame.html. Accessed 31 March 2008.
13. Gross P.A., Denning C.R., Gaerlan P.F., Bonelli J., Bernius M., and Dran S. Annual influenza vaccination: immune response in patients over 10 years. Vaccine 14 (1996) 1280-1284
14. Malfroot A., Adam G., Cliofu O., Doring G., Knoop C., and Lang A.B. for the European Cystic Fibrosis Society (ECFS) vaccination group. Immunisation in the current management of cystic fibrosis patient. J Cyst Fibros. 4 (2005) 77-87
15. Calendrier vaccinal 2007-Avis du Haut Conseil de la Santé Publique. BEH 2007; 31-32:269-88.
16. Calendrier vaccinal. BEH 1986; 52:206-7.
17. Calendrier vaccinal 2000. Avis du Conseil Supérieur d'Hygiène Publique de France BEH 2000; 27:115-7.
18. Vaincre la mucoviscidose. La mucoviscidose. Etre muco. Les patients atteints de mucoviscidose en France (French). Available at: http://www.vaincrelamuco.org/ewb_pages/e/etre-muco.php. Accessed 31 March 2008.
19. Circulaire DHOS/O 1/DGS/SD 5 n° 2001-502 du 22 octobre 2001 relative à l'organisation des soins pour la prise en charge des patients atteints de mucoviscidose. NOR: MESH0130696C. Available at: http://www.sante.gouv.fr/adm/dagpb/bo/2001/01-50/a0503306.htm Accessed 31 March 2008.
20. Sécurité sociale. L'assurance maladie. Qu'est-ce qu'une ALD. Available at: http://www.ameli.fr/assures/droits-et-demarches/par-situation-medicale/en-cas-d-affection-de-longue-duree/qu-8217-est-ce-qu-8217-une-a.l.d.php Accessed 31 March 2008.
21. Wat D, Gelder C, Hibbitts S, Cafferty F, Bowler I, Pierrepoint M, Evans R, Doull I. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros. 2008 Feb 4. [Epub ahead of print].
22. Clifton I.J., Kastelik J.A., Peckham D.G., Hale A., Denton M., and Etherington C. Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol Infect. 136 (2008) 128-134
23. TNS Sofres Santé. Bilan de la vaccination anti-grippale hiver 2004-2005. Press conference of September 19, 2005. 68 BG 16-Mars 2005. pp. 62.
24. Weil-Olivier C., Angoulvant F., Chevallier B., De Montalembert M., Gaudelus J., and Quinet B. [Influenza vaccine coverage rate in children with underlying chronic disorders in 7 French pediatric wards] (in French). Arch Pediatr. 13 (2006) 1287-1293
25. Marshall B.C., Henshaw C., Evans D.A., Bleyl K., Alder S., and Liou T.G. Influenza vaccination coverage level at a cystic fibrosis center. Pediatrics 109 (2002) 1-4
26. Zindani G.N., Streetman D.D., Streetman D.S., and Nasr S.Z. Adherence to treatment in children and adolescent patients with cystic fibrosis. J Adolesc. Health 38 (2006) 13-17
27. International Society for Heart and Lung Transplantation (ISHLT) Transplant Registry Quarterly Reports for Lung in Europe. Characteristics for Transplants performed between January 1, 2006 and June 30, 2007. Available at: http://www.ishlt.org/registries/quarterlyDataReportResults.asp?organ=LU&rptType=tx_demo&continent=3 Accessed 31 March 2008.
28. Soesman N.M., Rimmelzwaan G.F., Nieuwkoop N.J., Beyer W.E., Tilanus H.W., and Kemmeren M.H. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 61 (2000) 85-93
29. Briggs J.D., Timbury M.C., Paton A.M., and Bell P.R.F. Viral infection and renal transplant rejection. Br Med J 4 (1972) 520-522
30. Ballout A., Goffin E., Yombi J.C., and Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc. 37 (2005) 2826-2827
31. Britto M.T., Schoettker J., Pandzik G.M., Weiland J., and Mandel K.E. Improving influenza immunization for high-risk children and adolescents. Qual. Saf. Health Care 16 (2007) 363-368